Financial Ratios

KILITCH DRUGS (INDIA) LTD.

NSE : KILITCHBSE : 524500ISIN CODE : INE729D01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE389.85-0.35 (-0.09 %)
PREV CLOSE ( ) 390.20
OPEN PRICE ( ) 391.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2533
TODAY'S LOW / HIGH ( )371.10 392.50
52 WK LOW / HIGH ( )136.55 469.85
NSE388.90-0.7 (-0.18 %)
PREV CLOSE( ) 389.60
OPEN PRICE ( ) 400.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 388.90 (2998)
VOLUME 17345
TODAY'S LOW / HIGH( ) 370.15 400.00
52 WK LOW / HIGH ( )138 470
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)10.096.763.972.899.62
   CEPS(Rs)10.947.374.713.6310.40
   DPS(Rs)0.000.000.000.000.50
   Book NAV/Share(Rs)122.30112.42104.9397.4897.66
   Tax Rate(%)19.1924.4118.0214.6524.37
Margin Ratios
   Core EBITDA Margin(%)14.7210.587.601.9216.17
   EBIT Margin(%)17.4914.0011.9510.1220.92
   Pre Tax Margin(%)16.5113.2410.708.5920.25
   PAT Margin (%)13.3410.018.777.3315.32
   Cash Profit Margin (%)14.4810.9310.409.2316.56
Performance Ratios
   ROA(%)6.534.953.352.599.38
   ROE(%)8.596.233.932.9710.65
   ROCE(%)9.907.834.913.7913.79
   Asset Turnover(x)0.490.490.380.350.61
   Sales/Fixed Asset(x)3.183.302.552.273.79
   Working Capital/Sales(x)2.022.401.791.792.21
Efficiency Ratios
   Fixed Capital/Sales(x)0.310.300.390.440.26
   Receivable days146.46111.66103.82120.5183.03
   Inventory Days10.9214.9023.7830.8314.22
   Payable days176.61125.20100.2868.2845.22
Valuation Parameters
   PER(x)13.8424.8220.4028.1420.56
   PCE(x)12.7522.7417.2122.3519.01
   Price/Book(x)1.141.490.770.832.02
   Yield(%)0.000.000.000.000.25
   EV/Net Sales(x)1.882.661.922.223.20
   EV/Core EBITDA(x)10.0917.8014.1218.5014.45
   EV/EBIT(x)10.7518.9616.0421.9715.31
   EV/CE(x)0.881.210.690.781.81
   M Cap / Sales1.852.481.792.063.15
Growth Ratio
   Net Sales Growth(%)12.0050.1915.22-36.9791.09
   Core EBITDA Growth(%)39.8264.7030.36-65.81144.03
   EBIT Growth(%)39.9075.6136.24-69.49166.57
   PAT Growth(%)49.2971.0338.10-69.82138.34
   EPS Growth(%)49.2970.0737.57-69.97113.14
Financial Stability Ratios
   Total Debt/Equity(x)0.110.120.090.080.06
   Current Ratio(x)2.031.812.212.543.13
   Quick Ratio(x)2.001.722.102.292.90
   Interest Cover(x)17.9318.529.576.6131.26
   Total Debt/Mcap(x)0.100.080.120.100.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.